Nature Genetics

Nature Genetics
Title	Nature Genetics
Discipline	Genomics; Molecular Biology; Genetics
Abbreviation	Nat. Genet.
Editor	_see Editorial Board and Publication Practices_
Country	United Kingdom
History	1992–present
Frequency	Monthly
Impact	_see Impact and Reception_

Nature Genetics Nature Genetics is a monthly peer-reviewed scientific journal publishing research in genomics, molecular biology, population genetics, functional genomics, and related areas. As part of the Nature Portfolio of journals produced by Springer Nature, the journal occupies a prominent role alongside titles such as Nature Biotechnology, Nature Medicine, Nature Communications, and Nature Reviews Genetics. It regularly features original research, reviews, and commentary that intersect with institutions including the Broad Institute, Wellcome Sanger Institute, Max Planck Society, and Howard Hughes Medical Institute.

History

The journal was launched in 1992 during a period marked by large-scale projects like the Human Genome Project and collaborations among groups such as the International HapMap Consortium and the 1000 Genomes Project. Early editorial leadership established relationships with centers such as Cold Spring Harbor Laboratory, European Molecular Biology Laboratory, and universities including Harvard University, Stanford University, University of Cambridge, University of Oxford, and Massachusetts Institute of Technology. Over subsequent decades Nature Genetics covered milestones tied to the ENCODE Project Consortium, the rise of next-generation sequencing technologies from companies like Illumina and Pacific Biosciences, and breakthroughs at companies such as Genentech and 23andMe. The journal’s trajectory reflects broader shifts seen in initiatives like Personal Genome Project and consortia including GTEx Consortium.

Scope and Content

The journal’s remit spans topics that connect laboratories, clinics, and computational centers: human genetic variation studied at institutions like Mayo Clinic and Johns Hopkins University; model-organism genetics from groups at University of California, Berkeley and European Molecular Biology Organization labs; and computational methods developed in groups at Google DeepMind, Microsoft Research, and the European Bioinformatics Institute. Content types include primary research, methodological advances, large-scale datasets (akin to work from the UK Biobank), meta-analyses involving consortia such as the Psychiatric Genomics Consortium, and commentaries engaging funders like the Wellcome Trust, National Institutes of Health, and Bill & Melinda Gates Foundation. The scope also overlaps policy debates involving agencies like the Food and Drug Administration and regulatory frameworks informed by agencies such as the European Medicines Agency.

Editorial Board and Publication Practices

The editorial model involves professional editors working with academic editorial board members drawn from universities such as Yale University, Princeton University, University of California, San Francisco, ETH Zurich, and University of Toronto. Peer review engages reviewers affiliated with centers like Sanger Institute, Fred Hutchinson Cancer Research Center, Karolinska Institutet, and national academies including the National Academy of Sciences and the Royal Society. The journal has adopted policies on data availability and reproducibility influenced by standards from organizations such as the Committee on Publication Ethics and the International Committee of Medical Journal Editors. Editorial decisions have intersected with debates involving preprint servers like bioRxiv and medRxiv, and with open-science advocates including the Open Science Framework.

Impact and Reception

Nature Genetics is widely cited in literature produced by groups at Harvard Medical School, Stanford School of Medicine, Cambridge Biomedical Campus, and corporate research arms like Regeneron Pharmaceuticals. Its articles contribute to citation networks that include Cell, Science Translational Medicine, Genome Research, and Proceedings of the National Academy of Sciences. The journal’s impact factor and metrics are tracked by services such as Clarivate Analytics and Scopus (Elsevier). Reception spans acclaim for landmark genomic reports and criticism in contexts involving reproducibility debates and discussions of authorship practices highlighted by commentators at Retraction Watch and policy analysts from The Wellcome Trust. Nature Genetics has featured work that shaped guidelines from organizations like the American College of Medical Genetics and Genomics.

Notable Papers and Contributions

Published work in the journal has included genome-wide association studies led by consortia such as the GIANT Consortium and the CARDIoGRAMplusC4D Consortium, population sequencing efforts linked to the Icelandic deCODE Genetics program, and methodological papers on variant calling and imputation that influenced pipelines at the 1000 Genomes Project and Haplotype Reference Consortium. Seminal contributions have come from labs associated with Nobel laureates and awardees recognized by institutions including the Lasker Foundation and the Royal Society. The journal has disseminated influential studies on cancer genomics from groups at Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute, as well as neurogenetics work tied to groups at Massachusetts General Hospital and the Salk Institute.

Abstracting and Indexing

Nature Genetics is indexed and abstracted in major services such as PubMed, MEDLINE, Web of Science, Scopus, and EMBASE. Its metadata appear in aggregators and discovery platforms used by libraries at Library of Congress, university systems like University of California and University of Oxford, and research infrastructures including CrossRef and ORCID. Citation analyses referencing the journal make use of tools from Google Scholar, Dimensions, and bibliometric platforms operated by Clarivate Analytics.

Category:Genetics journals